Research Site — Danvers, Massachusetts

Research Site is a clinical research site located in Danvers, Massachusetts, United States 01923.

Crixeo Clinical Trials Trust Score: 12/100 (FAILING). This profile has not yet been claimed by the site owner.

Research Site has participated in 5 clinical trials with 1 currently active.

Therapeutic areas: Cancer, Hematologic Malignancies, Multiple Myeloma.

Sponsors: Amgen, AstraZeneca, MedImmune LLC.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Danvers

Browse all research sites in Massachusetts · View every site in Danvers

• Massachusetts General Hospital/North Shore Cancer Center
• Massachusetts General Hospital/North Shore Center for Outpatient Care
• Massachusetts General Hospital,102 Endicott Street
• Massachusetts General Hospital
• Mass General/North Shore Cancer Center
• MGH/North Shore Cancer Center
• NSMC Cancer Center - Peabody
• Mass General at North Shore Cancer Center
• Mass General/North Shore Center for Outpatient Care
• Care Dimensions
• Mass General/North Shore Cancer

Sponsor Feasibility Report

Trust Score: 12/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Research Site?

Research Site has a Crixeo Trust Score of 12/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Research Site conducted?

Research Site has 5 clinical trials on record, with 1 currently active. Their work covers Cancer, Hematologic Malignancies, Multiple Myeloma.

Is Research Site accredited by Crixeo Clinical Trials?

Research Site has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Research Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.